| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Savara Inc (SVRA) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. SVRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.53M | $13.07M | - | |
| CEO | 1.19M | $6.13M | - | |
| Other | 519.2K | $2.68M | - | |
| Other | 371.7K | $1.92M | - | |
| Dir | 300.8K | $1.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Ramsay David A76 | Director | Sell | 20,000 | $6.06 | $121,220.00 | -0.8% | -14.7% | - | |
| Jun 20, 2025 | Hawkins Richard J | Director | Buy | 48,225 | $2.04 | $98,571.90 | +71.7% | +74.8% | - | |
| May 29, 2025 | McCracken Joseph S47 | Director | Buy | 10,000 | $2.08 | $20,825.00 | +4.0% | +46.9% | - | |
| Mar 31, 2025 | Ramsay David A76 | Director | Buy | 150,000 | $2.78 | $416,250.00 | +6.3% | -17.7% | +97.1% | |
| Dec 16, 2024 | Lowrance David L47 | Chief Financial Officer | Sell | 25,000 | $3.33 | $83,277.50 | -6.2% | -13.8% | +97.2% | |
| Dec 16, 2024 | Pauls Matthew66 | Chief Executive Officer | Sell | 54,702 | $3.31 | $180,828.40 | -3.4% | -13.8% | +97.2% | |
| Dec 16, 2024 | Hawkins Richard J | Director | Sell | 8,000 | $3.32 | $26,568.80 | -10.6% | -13.8% | +97.2% | |
| Nov 19, 2024 | McCracken Joseph S47 | Director | Buy | 20,000 | $2.95 | $59,072.00 | +10.5% | -3.1% | +56.5% | |
| Nov 18, 2024 | Ramsay David A76 | Director | Buy | 100,000 | $2.88 | $287,600.00 | +4.5% | -3.7% | +40.9% | |
| Dec 28, 2023 | Elam Nevan C76 | Director | Sale+OE | 93,843 | $4.71 | $442,291.44 | -80.7% | +0.6% | -34.6% |